Vimarsana
Biggest News Aggregation in the World

Page 2 - Mark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Diagnostics Today - Breaking & Trending Today

World Syndromic Multiplex Diagnostic Markets, 2024-2029: How Syndromic Molecular Diagnostics is Replacing Traditional Panel-based Ordering of Infectious Disease Tests - Vimarsana News

World Syndromic Multiplex Diagnostic Markets, 2024-2029: How Syndromic Molecular Diagnostics is Replacing Traditional Panel-based Ordering of Infectious Disease Tests

/PRNewswire/ -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.),...

World Molecular Diagnostics Market Research Report 2023-2028 - Companion Diagnostics and Molecular Pharmacokinetics Revolutionizes Drug Therapies - Vimarsana News

World Molecular Diagnostics Market Research Report 2023-2028 - Companion Diagnostics and Molecular Pharmacokinetics Revolutionizes Drug Therapies

/PRNewswire/ -- The "The World Market for Molecular Diagnostics, 12th Edition" report has been added to ResearchAndMarkets.com's offering. The World Market for...

Global Syndromic Multiplex Panels Market Trends Analysis Report 2023-2028: PCR Takes Command, Bioinformatics Plays a Role, Traditional Automation and Centralization, NGS Fuels a Revolution - Vimarsana News

Global Syndromic Multiplex Panels Market Trends Analysis Report 2023-2028: PCR Takes Command, Bioinformatics Plays a Role, Traditional Automation and Centralization, NGS Fuels a Revolution

/PRNewswire/ -- The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and...

BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay - Vimarsana News

BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay

BioMark Diagnostics Inc. a clinical and diagnostic laboratory developing a liquid biopsy molecular diagnostic tests with a focus on hard to detect and treat cancers, is pleased to announce today...

BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium - Vimarsana News

BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium

BioMark Diagnostics Inc. a leading liquid biopsy company focusing on metabolomics for the early diagnosis of hard to detect and treat cancers is pleased to announce today that its abstract has...